Feb 02, 2021
By Jane Brown
The prime minister is expected to announce on Tuesday an agreement to produce COVID-19 vaccines within Canada.
According to a published report, Justin Trudeau will likely announce that Novavax will produce its COVID-19 vaccine at a still-under-construction facility in Montreal.
The National Post quotes an unnamed government source as saying Novavax has signed a memorandum of understanding to use the National Research Council’s facility and could begin producing vaccines in late July.
Canada’s inability to produce any COVID-19 vaccines at home has left the country at the mercy of foreign governments, primarily in Europe, which so far have pledged not to cut off shipments of COVID-19 vaccines bound for Canada.
(Dr. Rhonda Flores looks at protein samples at Novavax labs in Rockville, Maryland on March 20, 2020 which is one of the labs developing a vaccine for the coronavirus. ANDREW CABALLERO-REYNOLDS/AFP via Getty Images/CNN)
Novavax scientists have been working on their vaccine since the beginning of the pandemic. The U.S. pharmaceutical company, based in Maryland, already has an order to supply Canada with 52 million doses of its vaccine and is now seeking regulatory approval from Health Canada.
The vaccine requires two doses, but can be stored in normal fridges and isn’t as delicate as the two approved vaccines made by Pfizer-BioNTech and Moderna.